Synopsis
Synopsis
0
JDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1,8-diacetoxy-3-carboxyanthraquinone
2. 2-anthracenecarboxylic Acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-
3. 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic Acid
4. 4,5-diacetoxyanthraquinone-2-carboxylic Acid
5. 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic Acid, Diacetate
6. Ac-201
7. Ac-203
8. Artrodar
9. Diacerhein
10. Diacetyl-rhein
11. Diacetylrhein
12. Diora
13. Fisiodar
14. M-01ax21
15. M01ax21
16. Rhein Diacetate
17. Sf-277
18. Sf277
19. Verboril
20. Zondar
1. 13739-02-1
2. Diacerhein
3. Diacetylrhein
4. Artrodar
5. Fisiodar
6. 1,8-diacetoxy-3-carboxyanthraquinone
7. Diacerin
8. Sf-277
9. Verboril
10. Zondar
11. Diora
12. 4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic Acid
13. M01ax21
14. Ac-201
15. 2-anthracenecarboxylic Acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-
16. 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic Acid
17. 4,5-diacetoxyanthraquinone-2-carboxylic Acid
18. M-01ax21
19. Diacerhein; Diacetylrhein
20. Mfcd00468030
21. Nsc-758147
22. Mls000028577
23. 4hu6j11el5
24. 4,5-diacetoxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic Acid
25. 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic Acid, Diacetate
26. 4,5-diacetylrhein
27. Ncgc00018274-04
28. Smr000058958
29. 4,5-bis(acetyloxy)-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic Acid
30. Dsstox_cid_25636
31. Dsstox_rid_81017
32. Diacerein [inn]
33. Dsstox_gsid_45636
34. Diacereine [french]
35. Diacereinum [latin]
36. Diacereina [spanish]
37. 4,5-diacetoxy-9,10-diketo-anthracene-2-carboxylic Acid
38. 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic Acid
39. Diacereina
40. Diacereine
41. Diacereinum
42. Rhein Diacetate
43. Rhein, Diacetate
44. Cas-13739-02-1
45. Sr-01000003156
46. Einecs 237-310-2
47. Brn 2184909
48. Unii-4hu6j11el5
49. Gesamtmatrix
50. Art 50
51. 1,8-diacetoxyanthraquinone-3-carboxylic Acid
52. Diacerein- Bio-x
53. Zondar (tn)
54. Spectrum_001876
55. Specplus_000643
56. 4,5-diacetoxy-9,10-dihydro-9,10-dioxo-2-anthrylcarbonsaeure
57. 9,10-dihydro-4,5-diacetoxy-9,10-2-anthracenecarboxylic Acid
58. Diacerein [mi]
59. Diacerein (usan/inn)
60. Diacerein [usan:inn]
61. Diacerein [usan]
62. 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic Acid Diacetate
63. Spectrum2_000823
64. Spectrum3_000937
65. Spectrum4_001036
66. Spectrum5_001819
67. Diacerein Impurity Mixture
68. Diacerein [mart.]
69. Diacerein [who-dd]
70. Schembl25784
71. Kbiogr_001591
72. Kbioss_002400
73. Rhein Diacetate [mi]
74. 3-10-00-04790 (beilstein Handbook Reference)
75. Cid_26248
76. Chembl41286
77. Divk1c_006739
78. Spectrum1502010
79. Spbio_000745
80. 4,5-diacetoxy-9,10-dioxo-anthracene-2-carboxylic Acid
81. Diacerein [ep Monograph]
82. Diacerein, >=95% (hplc)
83. Dtxsid4045636
84. Bdbm32018
85. Chebi:94708
86. Gtpl10800
87. Kbio1_001683
88. Kbio2_002395
89. Kbio2_004963
90. Kbio2_007531
91. Kbio3_001974
92. Hms3652d06
93. Hms3714b20
94. Pharmakon1600-01502010
95. Bcp10834
96. Hy-n0283
97. Who 5371
98. Zinc3812842
99. Tox21_110856
100. Bbl011075
101. Ccg-40287
102. Nsc758147
103. S4267
104. Stk802271
105. 2-anthroic Acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-, Diacetate
106. Akos005622705
107. Tox21_110856_1
108. Db11994
109. Ks-5088
110. Kw-4800
111. Nsc 758147
112. Ncgc00018274-01
113. Ncgc00018274-02
114. Ncgc00018274-03
115. Ncgc00018274-05
116. Ncgc00022114-03
117. Am807992
118. Bd164367
119. Sbi-0052833.p002
120. B1726
121. D4061
122. Ft-0603096
123. Sw199355-2
124. D07270
125. Ab00053327_14
126. 739d021
127. A807252
128. Q413178
129. Sr-01000003156-2
130. Sr-01000003156-3
131. Sr-01000003156-4
132. W-108237
133. Diacerein, European Pharmacopoeia (ep) Reference Standard
134. 4,5-diacetoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic Acid
135. 4,5-diacetyloxy-9,10-bis(oxidanylidene)anthracene-2-carboxylic Acid
136. 4,5-bis(acetoxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic Acid
137. 112118-18-0
Molecular Weight | 368.3 g/mol |
---|---|
Molecular Formula | C19H12O8 |
XLogP3 | 1.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 368.05321734 g/mol |
Monoisotopic Mass | 368.05321734 g/mol |
Topological Polar Surface Area | 124 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 683 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of osteoarthritis affecting the hip or knee.
Decreases inflammation and cartilage destruction and also corrects altered osteoblast acitivity.
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AX - Other antiinflammatory and antirheumatic agents, non-steroids
M01AX21 - Diacerein
Absorption
Bioavailability of 50-60%. Entirely converted to the active metabolite rhein [DB13174] before reaching systemic circulation.
Route of Elimination
37% excreted in urine and 53% in feces as estimated in rats.
Volume of Distribution
15-60L.
Clearance
Total CL is 1.5L/h and renal CL is 0.1L/h.
Entirely converted to rhien [DB13174] through double deacetylation before reaching systemic circulation. Rhein [DB13174] is further metabolized to rhein glucuronide and rhein sulfate.
4-10h.
Diacerein's active metabolite rhein [DB13174] reduces cartilage destruction by decreasing expression of matrix metalloproteinase (MMP)-1 and -3 as well as upregulating tissue inhibitor of matrix metalloproteinases which serve to reduce the activity of several MMPs. The anti-inflammatory action of rhein reduces the level of interleukin-1beta activity which plays a large role in reduction of extracellular matrix production, MMP activity, and continued inflammation. Rhein reduces abnormal osteoblast synthetic activity through an unknown mechanism.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Reply
28 Dec 2023
Reply
16 Oct 2023
Reply
15 Jul 2023
Reply
01 Jun 2023
Reply
22 Apr 2023
Reply
18 Nov 2022
Reply
30 Sep 2022
Reply
25 Jul 2022
Reply
07 Jun 2022
Reply
25 May 2022
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?